IDENTIFICATION AND CHARACTERIZATION OF CIRCULAR RNAS AS NOVEL PUTATIVE BIOMARKERS TO PREDICT THE SURVIVAL BENEFIT AMONG METASTATIC MELANOMA PATIENTS TREATED WITH ANTI-PD-1 MONOTHERAPY

Zhou JG, Gaipl U, Ma H, Wang H (2022)

Publication Type: Conference contribution

Publication year: 2022

Journal

Journal for ImmunoTherapy of Cancer BioMed Central

Publisher: BMJ PUBLISHING GROUP

City/Town: LONDON

Pages Range: A20-A20

Conference Proceedings Title: JOURNAL FOR IMMUNOTHERAPY OF CANCER

DOI: 10.1136/jitc-2022-SITC2022.0018

Authors with CRIS profile

Udo Gaipl Medizinische Fakultät

Involved external institutions

Zunyi Medical University CN China (CN) US National Institutes of Health (NIH) US United States (USA) (US)

How to cite

APA:

Zhou, J.-G., Gaipl, U., Ma, H., & Wang, H. (2022). IDENTIFICATION AND CHARACTERIZATION OF CIRCULAR RNAS AS NOVEL PUTATIVE BIOMARKERS TO PREDICT THE SURVIVAL BENEFIT AMONG METASTATIC MELANOMA PATIENTS TREATED WITH ANTI-PD-1 MONOTHERAPY. In JOURNAL FOR IMMUNOTHERAPY OF CANCER (pp. A20-A20). LONDON: BMJ PUBLISHING GROUP.

MLA:

Zhou, Jian-Guo, et al. "IDENTIFICATION AND CHARACTERIZATION OF CIRCULAR RNAS AS NOVEL PUTATIVE BIOMARKERS TO PREDICT THE SURVIVAL BENEFIT AMONG METASTATIC MELANOMA PATIENTS TREATED WITH ANTI-PD-1 MONOTHERAPY." Proceedings of the JOURNAL FOR IMMUNOTHERAPY OF CANCER LONDON: BMJ PUBLISHING GROUP, 2022. A20-A20.

BibTeX: Download